Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
Predictors of Relapse and Dropout During a 12-week Relapse Prevention Program for Methamphetamine Users.
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey.
Health care service utilization and associated factors among heroin users in northern Taiwan.
Quetiapine Fumarate Augmentation for Patients with a Primary Anxiety Disorder or a Mood Disorder: a Pilot Study.
Association of Salivary Dehydoepiandrosterone Levels and Symptoms in Patients with Attention Deficit Hyperactivity Disorder during Six Months of Treatment with Methylphenidate.
Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α-induced Depresion by Regulating Polyunsaturated Fatty Acids Levels.
The Potential Risk Factors of Methadone Maintenance Therapy-A Mortality Case Report.
Clinical Effectiveness of Group Cognitive-behavioral Therapy for Primary and Secondary Insomnia.
Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder; a 12-month follow-up.
